Insmed (INSM) Short-term Investments (2010 - 2026)

Insmed has reported Short-term Investments for 9 years, with the latest figure at $615.5 million in Q2 2026.

• On a quarterly basis, Short-term Investments rose 7.53% year-over-year to $615.5 million in Q2 2026; TTM through Jun 2026 was $615.5 million, a 7.53% increase from a year earlier, with the FY2025 full-year figure at $919.6 million, up 4.64% from the prior year.
• Short-term Investments was $615.5 million for Q2 2026 at Insmed, down from $641.3 million in the prior quarter.
• The five-year high for Short-term Investments was $1.3 billion in Q3 2025, with the low at $29.8 million in Q1 2023.
• Average Short-term Investments over 5 years is $508.6 million, with a median of $438.7 million recorded in 2023.
• The largest YoY upside for Short-term Investments was 301.48% in 2023 against a maximum downside of 75.07% in 2023.
• Over 5 years, Short-term Investments stood at $74.2 million in 2022, then surged by 301.48% to $298.1 million in 2023, then jumped by 194.83% to $878.8 million in 2024, then rose by 4.64% to $919.6 million in 2025, then tumbled by 33.06% to $615.5 million in 2026.
• The last three Short-term Investments figures came in at $615.5 million (Q2 2026), $641.3 million (Q1 2026), and $919.6 million (Q4 2025), per Business Quant data.